Syndax Pharmaceuticals SNDX Change in receivables
Change in receivables at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's change in receivables.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Syndax Pharmaceuticals's change in receivables?
- Syndax Pharmaceuticals (SNDX) reported change in receivables of -$6.14M in Q1 2026.
- How has Syndax Pharmaceuticals's change in receivables changed year-over-year?
- Syndax Pharmaceuticals's change in receivables decreased by 13537.8% year-over-year, from -$45K to -$6.14M.
- What does change in receivables mean?
- Change in total receivables including trade and non-trade receivables.